Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae

Pneumonia remains the single leading cause of childhood death worldwide. Despite the commercial availability of multiple pneumococcal conjugate vaccines (PCVs), high dosage cost and supply shortages prevent PCV delivery to much of the developing world. The current work presents high-yield pneumococc...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Allison E.B. Turner, Jonas E. Gerson, Helen Y. So, Daniel J. Krasznai, Adrienne J. St. Hilaire, Donald F. Gerson
Format:	Artigo
Sprog:	Inglês
Udgivet:	KeAi Communications Co., Ltd. 2017-03-01
Serier:	Synthetic and Systems Biotechnology
Fag:	Pneumonia Vaccine development PCV Pneumococcal conjugate vaccine Polysaccharide Carrier protein In vacuo glycation
Online adgang:	http://www.sciencedirect.com/science/article/pii/S2405805X16300436
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!